Neuro-Oncology News

Jonathan T. Yang, MD, PhD, has been appointed associate vice chair for clinical research and developmental therapeutics in the department of radiation oncology at NYU Langone Health’s Perlmutter Cancer Center.

Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.

An mRNA cancer vaccine developed at University of Florida may have the ability to reprogram the immune system against glioblastoma, findings of a first-in-human trial showed.

Patients participating in clinical trials for anticancer drugs do not gain a survival benefit compared with individuals who received routine care, according to study results published in JAMA.

The prospect of screening for multiple cancer types simultaneously through a blood draw or other simple methods has generated tremendous excitement.

May is Brain Tumor Awareness Month.

AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

A phase 1 trial showed chimeric antigen receptor T-cell therapy may hold promise for the treatment of glioblastoma.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.